Vickers Venture Partners, a venture capital (VC) firm with a global footprint, has announced a Series A investment of US$3.5 million along with Exen Capital into the next-gen silicon nanotechnology drug delivery company SiSaf. Invest Northern Ireland, an investor in earlier rounds, also followed on in this round.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
